Woodline Partners
DBTX

Woodline Partners’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Woodline Partners’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-275,001
Closed -$836K – 921
2022
Q1 		$836K Hold
275,001
– – 0.01% 486
2021
Q4 		$1.28M Sell
275,001
-5,472
-2% -$37.7K 0.02% 484
2021
Q3 		$2.16M Sell
280,473
-38
-0% -$290 0.04% 403
2021
Q2 		$2.41M Hold
280,511
– – 0.05% 332
2021
Q1 		$3.19M Buy
+280,511
New +$4.4M 0.07% 241

Other funds holding DBTX

OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
Harvard Management Company
Harvard Management Company Boston, Massachusetts $4.26B AUM 5.81% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Woodline Partners's DBTX Position: Q2 2022 in Review

Woodline Partners sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q2 2022, closing a stake of 275,001 shares — an estimated $836K sold.

Woodline Partners first reported a position in DBTX in Q1 2021 and held it in 5 quarters. The position peaked at $3.19M in Q1 2021. 42 funds tracked by Wall St. Rank hold DBTX as of Q2 2022.

  • Woodline Partners reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Woodline Partners sold 275,001 Decibel Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $836K.
  • Woodline Partners first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • Woodline Partners's Decibel Therapeutics, Inc. Common Stock position peaked at $3.19M in Q1 2021.
  • 42 funds tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Woodline Partners's 13F filing for Q2 2022, filed 15 Aug 2022.